To provide the information your oncologist is not telling you or doesn't have the time to!
Here, we delve into the dynamic world of cutting-edge cancer treatments and therapies. Stay informed about groundbreaking advancements in cancer care, from emerging therapies to novel treatment modalities. Discover how science and technology are shaping the future of oncology, offering new hope and possibilities to those affected by cancer. Join us as we explore innovative approaches that hold the promise of brighter tomorrows for patients and their families.
“How am I doing?”, asked one of my colorectal patients. Ten years ago, I first met John (name changed for privacy), a warm and spirited individual diagnosed with stage 3 colon cancer. After undergoing surgical resection of the primary colon tumor and six months of standard adjuvant chemotherapy with mFOLFOX, John and I optimistically looked …
New article published in the NEJM confirming the high risk for gastric cancer with susceptible folks with H. Pylori infections. Another reason for me to check dna platforms such as 23andme! As a physician who not too long ago discovered my own asymptomatic H. pylori infection, I couldn’t help but wonder if there was more …
Metastatic gastric cancer, also known as stage IV gastric cancer, is a serious and advanced form of the disease in which the cancer has spread beyond the stomach to other parts of the body. The current standard of care for patients with metastatic gastric cancer includes chemotherapy, Her2 targeted therapy and immunotherapy. However, there remains …
KRAS is a gene that plays a key role in the growth and division of cells. Mutations in the KRAS gene can cause cancer, and one particular mutation called KRAS G12C occurs in about 1-2% of pancreatic cancers and 2-4% of colon cancers. These mutations make the cancer resistant to certain treatment options and are …